Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

Neoadjuvant chemotherapy with docetaxel, oxaliplatin, fluorouracil, and leucovorin (FLOT regimen) has shown promising results in terms of pathological response and survival rate in patients with locally advanced resectable gastric cancer (LAGC). However, tegafur gimeracil oteracil potassium capsule...

Descripción completa

Detalles Bibliográficos
Autores principales: Sah, Birendra Kumar, Zhang, Benyan, Zhang, Huan, Li, Jian, Yuan, Fei, Ma, Tao, Shi, Min, Xu, Wei, Zhu, Zhenglun, Liu, Wentao, Yan, Chao, Li, Chen, Liu, Bingya, Yan, Min, Zhu, Zhenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705676/
https://www.ncbi.nlm.nih.gov/pubmed/33257672
http://dx.doi.org/10.1038/s41467-020-19965-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705676/
https://www.ncbi.nlm.nih.gov/pubmed/33257672
http://dx.doi.org/10.1038/s41467-020-19965-6

Ejemplares similares